See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Ashford Hospitality Trust Inc (AHT) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ashford Hospitality Trust Inc (AHT) - free report >>
Image: Bigstock
New Strong Buy Stocks for October 23rd
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Manitex International, Inc. : This engineered lifting solutions company has seen the Zacks Consensus Estimate for its current year earnings increasing 63.6% over the last 60 days.
Manitex International, Inc. Price and Consensus
Manitex International, Inc. price-consensus-chart | Manitex International, Inc. Quote
ImmunoPrecise Antibodies Ltd. (IPA - Free Report) : This biotherapeutic research and technology company has seen the Zacks Consensus Estimate for its current year earnings increasing 37.5% over the last 60 days.
ImmunoPrecise Antibodies Ltd. Price and Consensus
ImmunoPrecise Antibodies Ltd. price-consensus-chart | ImmunoPrecise Antibodies Ltd. Quote
Ashford Hospitality Trust, Inc. (AHT - Free Report) : This real estate investment trust has seen the Zacks Consensus Estimate for its current year earnings increasing 35.5% over the last 60 days.
Ashford Hospitality Trust Inc Price and Consensus
Ashford Hospitality Trust Inc price-consensus-chart | Ashford Hospitality Trust Inc Quote
Vericel Corporation (VCEL - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 17.9% over the last 60 days.
Vericel Corporation Price and Consensus
Vericel Corporation price-consensus-chart | Vericel Corporation Quote
Alpine Immune Sciences, Inc. : This clinical-stage immunotherapy company has seen the Zacks Consensus Estimate for its current year earnings increasing 8.5% over the last 60 days.
Alpine Immune Sciences, Inc. Price and Consensus
Alpine Immune Sciences, Inc. price-consensus-chart | Alpine Immune Sciences, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.